Relay Therapeutics, Inc. (RLAY) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.61 | +31.8% |
| 2024 | $-2.36 | +15.4% |
| 2023 | $-2.79 | -7.7% |
| 2022 | $-2.59 | +32.2% |
| 2021 | $-3.82 | +29.3% |
| 2020 | $-5.40 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.61 | +31.8% |
| 2024 | $-2.36 | +15.4% |
| 2023 | $-2.79 | -7.7% |
| 2022 | $-2.59 | +32.2% |
| 2021 | $-3.82 | +29.3% |
| 2020 | $-5.40 | — |